Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals EBITDA Margin 2010-2023 | JAZZ

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Jazz Pharmaceuticals (JAZZ) over the last 10 years. The current EBITDA margin for Jazz Pharmaceuticals as of December 31, 2023 is .
  
Jazz Pharmaceuticals EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $3.83B $1.22B 31.74%
2023-09-30 $3.79B $0.82B 21.51%
2023-06-30 $3.76B $0.67B 17.88%
2023-03-31 $3.74B $0.58B 15.49%
2022-12-31 $3.66B $0.56B 15.38%
2022-09-30 $3.59B $0.90B 24.99%
2022-06-30 $3.48B $0.60B 17.17%
2022-03-31 $3.30B $0.76B 22.87%
2021-12-31 $3.10B $0.72B 23.36%
2021-09-30 $2.86B $0.75B 26.33%
2021-06-30 $2.63B $0.83B 31.44%
2021-03-31 $2.44B $1.00B 41.12%
2020-12-31 $2.36B $0.66B 27.79%
2020-09-30 $2.28B $0.62B 27.06%
2020-06-30 $2.22B $0.56B 25.30%
2020-03-31 $2.19B $0.65B 29.47%
2019-12-31 $2.16B $0.90B 41.77%
2019-09-30 $2.06B $0.95B 45.96%
2019-06-30 $1.99B $0.98B 49.52%
2019-03-31 $1.95B $0.92B 47.21%
2018-12-31 $1.89B $0.88B 46.35%
2018-09-30 $1.85B $0.84B 45.30%
2018-06-30 $1.79B $0.73B 40.83%
2018-03-31 $1.69B $0.66B 38.89%
2017-12-31 $1.62B $0.73B 44.81%
2017-09-30 $1.58B $0.79B 50.22%
2017-06-30 $1.54B $0.74B 48.28%
2017-03-31 $1.53B $0.75B 48.89%
2016-12-31 $1.49B $0.73B 48.92%
2016-09-30 $1.43B $0.59B 41.13%
2016-06-30 $1.40B $0.66B 47.11%
2016-03-31 $1.35B $0.64B 47.41%
2015-12-31 $1.33B $0.64B 48.23%
2015-09-30 $1.31B $0.67B 51.14%
2015-06-30 $1.28B $0.60B 47.18%
2015-03-31 $1.24B $0.56B 45.18%
2014-12-31 $1.17B $0.34B 29.24%
2014-09-30 $1.08B $0.29B 27.20%
2014-06-30 $1.01B $0.32B 31.51%
2014-03-31 $0.92B $0.27B 29.69%
2013-12-31 $0.87B $0.43B 48.97%
2013-09-30 $0.82B $0.40B 48.29%
2013-06-30 $0.76B $0.35B 46.07%
2013-03-31 $0.68B $0.31B 45.59%
2012-12-31 $0.59B $0.27B 46.17%
2012-09-30 $0.49B $0.22B 45.38%
2012-06-30 $0.38B $0.18B 46.88%
2012-03-31 $0.33B $0.16B 49.54%
2011-12-31 $0.27B $0.14B 50.18%
2011-09-30 $0.24B $0.13B 51.65%
2011-06-30 $0.21B $0.11B 49.07%
2011-03-31 $0.19B $0.08B 43.39%
2010-12-31 $0.17B $0.07B 38.73%
2010-09-30 $0.16B $0.05B 33.54%
2010-06-30 $0.14B $0.04B 29.86%
2010-03-31 $0.14B $0.04B 28.37%
2009-12-31 $0.13B $0.03B 19.53%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.871B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.423B 32.29
Chugai Pharmaceutical (CHGCY) Japan $52.640B 23.53
Takeda Pharmaceutical (TAK) Japan $41.839B 8.47
Merck (MKGAF) Germany $23.264B 22.56
Astellas Pharma (ALPMY) Japan $17.156B 27.09
Sandoz Group AG (SDZNY) Switzerland $15.184B 0.00
Neurocrine Biosciences (NBIX) United States $14.320B 39.20
Shionogi (SGIOY) Japan $13.522B 11.75
United Therapeutics (UTHR) United States $12.165B 12.97
Catalent (CTLT) United States $10.021B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.670B 0.00
Revolution Medicines (RVMD) United States $6.502B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.446B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.690B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.053B 0.00
Summit Therapeutics (SMMT) United States $3.117B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.076B 0.00
Corcept Therapeutics (CORT) United States $2.924B 26.50
PTC Therapeutics (PTCT) United States $2.538B 0.00
Dyne Therapeutics (DYN) United States $2.419B 0.00
Indivior (INDV) United States $2.340B 11.09
Recursion Pharmaceuticals (RXRX) United States $2.210B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.105B 11.96
Catalyst Pharmaceuticals (CPRX) United States $1.948B 18.95
Evotec AG (EVO) Germany $1.860B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.830B 0.00
Ardelyx (ARDX) United States $1.817B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.808B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.590B 27.83
Soleno Therapeutics (SLNO) United States $1.542B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.489B 0.00
Pacira BioSciences (PCRX) United States $1.435B 13.64
Xencor (XNCR) United States $1.420B 0.00
4D Molecular Therapeutics (FDMT) United States $1.310B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.296B 0.00
Cassava Sciences (SAVA) United States $1.109B 0.00
Cronos Group (CRON) Canada $1.108B 0.00
Enliven Therapeutics (ELVN) United States $1.084B 0.00
Collegium Pharmaceutical (COLL) United States $1.062B 6.35
Ironwood Pharmaceuticals (IRWD) United States $1.014B 15.80
Centessa Pharmaceuticals (CNTA) United Kingdom $1.003B 0.00
Ocular Therapeutix (OCUL) United States $0.956B 0.00
USANA Health Sciences (USNA) United States $0.933B 15.26
ProKidney (PROK) United States $0.930B 0.00
Relay Therapeutics (RLAY) United States $0.881B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.822B 0.00
Sage Therapeutics (SAGE) United States $0.704B 0.00
Lyell Immunopharma (LYEL) United States $0.699B 0.00
Silence Therapeutics (SLN) United Kingdom $0.688B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.661B 0.00
Exscientia (EXAI) United Kingdom $0.629B 0.00
Savara (SVRA) United States $0.619B 0.00
Harrow (HROW) United States $0.593B 0.00
Altimmune (ALT) United States $0.568B 0.00
Siga Technologies (SIGA) United States $0.541B 6.92
OmniAb (OABI) United States $0.521B 0.00
Korro Bio (KRRO) United States $0.507B 0.00
Bioventus (BVS) United States $0.505B 19.33
KalVista Pharmaceuticals (KALV) United States $0.503B 0.00
Verve Therapeutics (VERV) United States $0.502B 0.00
Heron Therapeutics (HRTX) United States $0.482B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.481B 0.00
Larimar Therapeutics (LRMR) United States $0.471B 0.00
Lexeo Therapeutics (LXEO) United States $0.456B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Tourmaline Bio (TRML) United States $0.386B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.368B 0.00
Organogenesis (ORGO) United States $0.363B 68.50
Nanobiotix S.A (NBTX) France $0.341B 0.00
Fractyl Health (GUTS) United States $0.338B 0.00
Nektar Therapeutics (NKTR) United States $0.322B 0.00
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.57
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.257B 0.00
ESSA Pharma (EPIX) Canada $0.253B 0.00
Pyxis Oncology (PYXS) United States $0.244B 0.00
Akebia Therapeutics (AKBA) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.240B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Prelude Therapeutics (PRLD) United States $0.220B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Acrivon Therapeutics (ACRV) United States $0.201B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.192B 234.67
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
VAXART, INC (VXRT) United States $0.170B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Incannex Healthcare (IXHL) Australia $0.159B 0.00
Elite Pharmaceuticals (ELTP) United States $0.153B 14.30
Context Therapeutics (CNTX) United States $0.150B 0.00
Cardiol Therapeutics (CRDL) Canada $0.148B 0.00
OptiNose (OPTN) United States $0.142B 0.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Vivani Medical (VANI) United States $0.110B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
SCYNEXIS (SCYX) United States $0.105B 1.47
Assertio Holdings (ASRT) United States $0.102B 4.65
Relmada Therapeutics (RLMD) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.096B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Jaguar Animal Health (JAGX) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.071B 0.00
Journey Medical (DERM) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Protara Therapeutics (TARA) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Inotiv (NOTV) United States $0.050B 0.00
Nutriband (NTRB) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.047B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Lipocine (LPCN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.031B 0.00
JanOne (JAN) United States $0.030B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
PolyPid (PYPD) Israel $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
SHINECO (SISI) China $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.12
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.10